Intracranial Fungal Infection After Solid-Organ Transplant

被引:4
作者
Sahinturk, Fikret [1 ]
Demirkaya, Hamiyet [2 ]
Dere, Umit Akin [1 ]
Sonmez, Erkin [1 ]
Altinors, Nur [1 ]
Moray, Gokhan [3 ]
Haberal, Mehmet [3 ]
机构
[1] Baskent Univ, Sch Med, Dept Neurosurg, 10 Sokak,45, TR-06490 Ankara, Turkey
[2] Baskent Univ, Sch Med, Dept Infect Dis, Ankara, Turkey
[3] Baskent Univ, Sch Med, Dept Gen Surg, Ankara, Turkey
关键词
Liver transplantation; Neurosurgical intervention; Renal transplantation; CENTRAL-NERVOUS-SYSTEM; LIPOSOMAL AMPHOTERICIN-B; INVASIVE ASPERGILLOSIS; ANTIFUNGAL THERAPY; SURVIVAL; GUIDELINES; RECIPIENTS;
D O I
10.6002/ect.TOND-TDTD2017.P56
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Neurologic complications after solid-organ transplant reveal a great spectrum of pathologies. Intracranial hemorrhages, cerebral ischemic lesions, infarctions, lymphoproliferative disorders, and infections, including aspergillosis, have been observed after liver transplant. Fungi constitute nearly 5% of all central nervous system infections, mainly occurring in immunocompromised patients. The most common causative agent is Aspergillus species. It presents either as maxillary sinusitis or pulmonary infection. Brain involvement of Aspergillus carries a high rate of mortality. Aspergillosis presents in the forms of meningitis, mycotic aneurysms, infarctions, and mass lesions. Aspergillosis does not have a specific radiologic appearance. Parenchymal aspergillosis has heterogenous signal intensity (hypointense on T1-weighted and hyperintense on T2-weighted images). Here, we present 3 patients who underwent solid-organ transplant and developed central nervous system aspergillosis. Different modalities of neurosurgical intervention were performed in combination with chemotherapy as part of their fungal therapy.
引用
收藏
页码:179 / 182
页数:4
相关论文
共 21 条
  • [1] COLEMAN JM, 1995, NEUROSURGERY, V36, P858, DOI 10.1097/00006123-199504000-00032
  • [2] Duchini A, 2002, SOUTH MED J, V95, P897
  • [3] An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
    Ellis, M
    Spence, D
    de Pauw, B
    Meunier, F
    Marinus, A
    Collette, L
    Sylvester, R
    Meis, J
    Boogaerts, M
    Selleslag, D
    Kremery, V
    von Sinner, W
    MacDonald, P
    Doyen, C
    Vandercam, B
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) : 1406 - 1412
  • [4] Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature
    Ergin, F
    Arslan, H
    Azap, A
    Demirhan, B
    Karakayali, H
    Haberal, M
    [J]. TRANSPLANT INTERNATIONAL, 2003, 16 (04) : 280 - 286
  • [5] Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery
    Iemmolo, RM
    Rossanese, A
    Rotilio, A
    Mattisi, G
    Gerunda, GE
    Merenda, R
    Neri, D
    Crepaldi, G
    Strazzabosco, M
    [J]. JOURNAL OF HEPATOLOGY, 1998, 28 (03) : 518 - 522
  • [6] Jain KK, 2007, NEUROL INDIA, V55, P241
  • [7] Kasper Ekkehard M, 2011, Surg Neurol Int, V2, P75, DOI 10.4103/2152-7806.81969
  • [8] MARTINEZ AJ, 1993, MODERN PATHOL, V6, P25
  • [9] Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation
    Patel, R
    Portela, D
    Badley, AD
    Harmsen, WS
    LarsonKeller, JJ
    Ilstrup, DM
    Keating, MR
    Wiesner, RH
    Krom, RAF
    Paya, CV
    [J]. TRANSPLANTATION, 1996, 62 (07) : 926 - 934
  • [10] Advances and challenges in management of invasive mycoses
    Patterson, TF
    [J]. LANCET, 2005, 366 (9490) : 1013 - 1025